Get started
Author

Elizabeth A. Raupach

Observed names: Elizabeth A Raupach, Elizabeth Raupach, Raupach, Elizabeth A, Raupach, Elizabeth A.
Observed institutions: University of Wisconsin–Eau Claire, Translational Genomics Research Institute, Mayo Clinic, University of Pittsburgh, Mayo Clinic in Arizona, Mayo Clinic Hospital
ORCID: 0000-0002-6034-007X
Observed ORCID: 0000-0002-6034-007X
OpenAlex ID: A5009548382
Analysis of recurrently protected genomic regions in cell-free DNA found in urine
2021 · Havell Markus, Jun Zhao, et al. · Science Translational Medicine · 97
PDF
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
2018 · Jessica D. Lang, William P. D. Hendricks, et al. · Clinical Cancer Research · 72
PDF
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
2020 · Krystal Ann Orlando, Amber K Douglas, et al. · eLife · 53
Improved methods for RNAseq-based alternative splicing analysis
2021 · Rebecca F. Halperin, Apurva Hegde, et al. · Scientific Reports · 48
PDF
The Paf1 Complex Broadly Impacts the Transcriptome of Saccharomyces cerevisiae
2019 · Mitchell A. Ellison, Alex R. Lederer, et al. · Genetics · 18
PDF
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
2022 · Bolni Marius Nagalo, Yumei Zhou, et al. · Hepatology · 15
PDF
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma
2023 · Chelsae R. Watters, Oumar Barro, et al. · Molecular Therapy — Oncolytics · 9
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al. · Cancer Research · 7
Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
2019 · Elizabeth A. Raupach, Krystine Garcia-Mansfield, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
2025 · Jessica D. Lang, William Selleck, et al. · iScience · 5
Evidence for Regulation of ECM3 Expression by Methylation of Histone H3 Lysine 4 and Intergenic Transcription in Saccharomyces cerevisiae
2016 · Elizabeth A Raupach, Joseph A Martens, et al. · G3 Genes Genomes Genetics · 4
PDF
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
2025 · Chelsae R. Watters, Oumar Barro, et al. · Molecular Therapy Oncology · 3
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience
2026 · Oluseyi Abidoye, Angelo Pirozzi, et al. · JCO Precision Oncology · 1
Abstract B065: Loss of SMARCA4 leads to intron retention and generation of tumor-associated antigens in small cell carcinoma of the ovary, hypercalcemic type
2025 · Elizabeth Raupach, Apurva Hegde, et al. · Cancer Research · 1
Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor Microenvironment
2025 · Natalie M Elliott, Benjamin L Kendall, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors
2020 · Yemin Wang, Dionzie Ong, et al. · Cancer Research · 1
Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
2020 · Elizabeth Raupach, Krystine Garcia-Mansfield, et al. · Cancer Research · 1
Loss of SMARCA4 leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
2026 · Huntsman, David, Lang, Jessica D, et al. · UNC Libraries
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response
2026 · Mulu Z. Tesfay, Aleksandra Cios, et al. · Journal for ImmunoTherapy of Cancer
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab
2026 · Naohiro Okano, Angelo Pirozzi, et al. · JCO oncology advances.
PDF
Supplementary Materials from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Supplementary Tables from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Data from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Supplemental Methods from Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
2023 · Jessica D. Lang, William P.D. Hendricks, et al.
Table S2 from Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
2023 · Jessica D. Lang, William P.D. Hendricks, et al.
Works count: 52
Citation count: 341
H-index: 7
I10-index: 6
Year
Topic
Type